Clinical Associate Professor Keith Ong is affiliated with the University of Sydney’s Northern Clinical School, specifically within the Department of Clinical Ophthalmology & Eye Health. His clinical specialty is Ophthalmology, with a focus on corneal endothelial health, glaucoma surgery outcomes, and cataract surgical techniques. His research addresses critical areas such as postoperative ocular toxicity, intraocular lens calculations, and infection control in eye surgeries. Dr. Ong’s publications (2011–2023) consistently explore topics like corneal endothelial changes post-trabeculectomy, refractive error management post-cataract surgery, and antibiotic prophylaxis strategies. Recent work emphasizes optimizing surgical techniques to reduce complications, such as BAK-induced corneal toxicity and IOL power calculation accuracy in LASIK patients. His work demonstrates a focus on improving surgical safety and precision, with studies evaluating alternative antibiotic delivery methods and laser therapy impacts. No awards or grants are explicitly noted in the provided text, but his contributions to clinical practice and surgical protocols are evident through his publication record.
Prof. Dr. Raphael Sznitman serves as Director of the ARTORG Center for Biomedical Engineering Research and Head of the Artificial Intelligence in Medical Imaging group at the University of Bern, Switzerland, holding a Full Professor position in AI for Medical Imaging since 2015. Education: PhD in Computer Science, Johns Hopkins University (2011) MSc in Computer Science, Johns Hopkins University (2009) BSc in Cognitive Systems, University of British Columbia (2007) Research Interests: Sznitman's work centers on computational vision , probabilistic methods , and statistical learning applied to medical imaging challenges. His group develops AI algorithms for ophthalmic diagnostics, surgical robotics, and medical image analysis, with emphasis on OCT, surgical phase recognition, and domain adaptation techniques. Key application areas include retinal disease detection and cataract surgery automation. Publication Trends: His 2021-2025 publications reveal concentrated efforts in deep learning for medical imaging , particularly in ophthalmology (OCT analysis) and surgical video understanding. Emerging themes include LLM applications for clinical monitoring, unsupervised out-of-distribution detection for surgical safety, and physics-informed AI for multimodal medical data fusion. Research Leadership: As ARTORG Center Director, Sznitman oversees interdisciplinary research bridging computer science and clinical medicine. His group collaborates extensively with Bern University Hospital clinicians on translational projects, securing funding for AI-driven diagnostic tools and surgical assistance systems. Current initiatives focus on real-time intraoperative guidance and spaceflight ophthalmology applications. Laboratory: The Artificial Intelligence in Medical Imaging group operates within ARTORG's dedicated facilities, maintaining partnerships with surgical robotics labs and ophthalmology departments for clinical validation of AI systems. Their work integrates multimodal data streams including OCT, VR perimetry, and surgical video feeds.
Professor Maryse Bailly is a Professor of Cell Biology at the UCL Institute of Ophthalmology, University College London, where she has been employed since December 2000, progressing from Lecturer to Reader/Associate Professor and finally to Professor in October 2020. Her research focuses on understanding fibroblast behavior in the context of ocular diseases, scarring, and fibrosis, with particular emphasis on cytoskeletal dynamics and mechanotransduction pathways. Education: Doctor of Philosophy, Universite Claude Bernard (Lyon 1), 1992 Diplome Universitaire de Technologie, Universite Claude Bernard (Lyon 1), 1983 Professor Bailly's research program investigates how fibroblasts sense and respond to mechanical and chemical stimuli in their environment, with applications to multiple ocular pathologies including trachoma, thyroid eye disease, glaucoma scarring, and myopia. Her laboratory has developed innovative in vitro and ex vivo models that allow the study of tissue contraction mechanisms within pseudo-physiological 3D environments, leading to the identification of novel therapeutic targets such as the Rac1 small GTPase and the MRTF/SRF pathway. She has established significant collaborations with clinicians at Moorfields Eye Hospital, particularly with Dr. Annegret Dahlmann-Noor on pediatric eye growth and myopia research. Analysis of Professor Bailly's publication record reveals a consistent focus on fibroblast mechanobiology with increasing emphasis on pediatric ocular development in recent years. Her work bridges fundamental cell biology with translational applications, particularly in understanding the biomechanical properties of fibroblasts in myopia development and post-surgical scarring. The research demonstrates strong interdisciplinary connections between ophthalmology, cell biology, and tissue engineering. Teaching: CELL0016 - Actin cytoskeleton and Intermediate Filaments CELL0017 - Fibrosis and mechanotransduction CELL0009 - Models organisms and techniques MECH0031 MSc Biomaterials & Tissue Engineering - Modeling tissue contraction and fibrosis
Dr. John Males is a Clinical Senior Lecturer at the University of Sydney and Director of Ophthalmology Training at Sydney Eye Hospital. His clinical and research expertise focuses on corneal surgery, cataract surgery, and laser vision correction. He pioneered Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Australia and is conducting clinical trials on Collagen Cross-Linking for keratoconus. His research spans corneal transplantation techniques, refractive error management, and ocular surface regeneration. Dr. Males holds roles as a consultant at major hospitals and serves as an examiner for the Royal Australian & New Zealand College of Ophthalmologists. Research interests include corneal biomechanics, surgical innovation for keratoconus, and outcomes analysis of cross-linking therapies. He leads studies on corneal densitometry, dry eye correlations, and long-term efficacy of surgical interventions. His work bridges clinical practice with translational research in regenerative medicine and ocular surface engineering. Publications span over 20 years, emphasizing corneal transplantation advancements, keratoconus management, and surgical complication resolution. His contributions to global consensus guidelines for endothelial keratoplasty highlight leadership in standardizing surgical practices.
Professor Gerard Sutton is an Honorary Professor in the Faculty of Medicine and Health at the University of Sydney, affiliated with the Save Sight Institute and Vision Eye Institute. He specializes in corneal and refractive surgery, combining clinical practice with research in keratoconus, corneal bioengineering, and global eye care. His work includes developing the Australian Corneal Bioengineering Centre and pioneering innovations like the Corneal Biopen for treating corneal defects. Research interests span clinical and laboratory-based studies, focusing on corneal transplantation, bioengineered treatments, and refractive surgery outcomes. Current projects include corneal bioengineering, keratoconus pathogenesis, and SMILE surgery clinical outcomes. He holds memberships in prominent ophthalmology societies like RANZCO and APPO. Awards: 2019 RANZCO John C. Parr Medal Lecture Award 2017 Sydney Research Centre ‘Big Idea’ Innovation Award 2015 XOVA Excellence in International Ophthalmology 2014 Asia Pacific Academy of Ophthalmology Achievement Award Grants & Funding: AU$35M BIENCO consortium (2023) for corneal blindness therapies AU$1.1M Corneal Biopen commercialization (2018) NHMRC Ideas Grant for bioengineered corneal layers (2019) His research group collaborates internationally, with projects addressing corneal transplantation equity, bioink development, and regenerative solutions for ocular surface diseases. Clinical affiliations include Sydney Eye Hospital and the Lions NSW Eye Bank.
Dr. Guangyao Li is a Research Fellow in the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge, affiliated with the Quantum Fluids research group. His work focuses on theoretical and computational studies of quantum fluids, particularly exciton-polaritons in semiconductor microcavities and their interactions with electrons and photons. His research bridges condensed matter physics, quantum optics, and nanotechnology. Dr. Li's interdisciplinary interests also extend to pharmacology and clinical medicine, evidenced by collaborative studies on drug efficacy, drug-related problems in hospital settings, and guidelines for off-label drug use in ophthalmology. These studies address topics such as glucocorticoid therapy complications, proton pump inhibitor utilization, and anti-vascular endothelial growth factor treatments for ocular diseases. His quantum physics publications explore polariton scattering, Bose-Einstein condensates, and chiral edge states in quantum fluids. Recent medical studies analyze drug safety, self-monitoring in diabetes, and inappropriate medication use in elderly cardiac patients. These works highlight his dual contribution to fundamental physics research and applied clinical pharmacology. No academic awards or grants are explicitly stated in available records. He advises no known students but collaborates across disciplines in Cambridge and Chinese medical institutions. His research is conducted within the Quantum Fluids group at DAMTP, leveraging advanced theoretical models and computational simulations.
Dr. Philippe Campeau is an Associate Clinical Professor in the Department of Pediatrics at the Faculty of Medicine, Université de Montréal. He is affiliated with CHU Sainte-Justine, a major pediatric hospital in Montreal, Quebec, where he works in the Medical Genetics Service. His clinical and research work focuses on genetic disorders affecting children, particularly in the areas of skeletal development and neurogenetics. Dr. Campeau obtained his Doctorate in Medicine from Laval University in Quebec (1998-2003) followed by specialty training in medical genetics at McGill University (2003-2008). He completed postdoctoral training at Baylor College of Medicine (2008-2013), which further developed his expertise in genetic research methodologies. His primary research interests include bone dysplasias , skeletal dysplasias , epilepsy , and epigenetic diseases . Dr. Campeau's laboratory identifies disease-causing genes, deciphers disease pathophysiology, and works to improve the management of children affected by these conditions. His work encompasses exome analysis , functional studies with cell lines and mouse models , and investigations into urea cycle abnormalities . He has made significant contributions to understanding genetic causes of conditions such as Genitopatellar syndrome (KAT6B), osteopetrosis, dysosteosclerosis (SLC29A3), osteogenesis imperfecta, early-onset osteoporosis (WNT1), Yunis-Varón syndrome (FIG4), and DOORS syndrome (TBC1D24). Dr. Campeau's publication record demonstrates a strong trajectory in medical genetics research, with numerous high-impact publications spanning from fundamental genetic discovery to translational research. His work spans skeletal disorders, neurodevelopmental conditions, and epigenetic mechanisms. Recent publications indicate an expanding focus on chromatin modifiers, DNA methylation patterns, and spliceosome function in neurodevelopmental conditions, reflecting the evolution of his research interests toward more complex molecular mechanisms. Dr. Campeau has received several research grants in recent years (6 starting in 2014) from organizations including the Fonds de la recherche en santé du Québec, Canadian Institutes of Health Research, and Fondation Grand Défi Pierre Lavoie. While specific students are not mentioned in the available information, as a clinical professor, he mentors medical students, residents, and research trainees in the Department of Pediatrics. His research is conducted as part of the 'Musculoskeletal Diseases and Rehabilitation' axis at CHU Sainte-Justine Research Center, where he collaborates with international research teams to identify disease-causing genes and develop better management strategies for children with genetic disorders.
Anja Liekfeld serves as Adjunct Professor of Ophthalmic Optics/Optical Device Technology at Brandenburg University of Technology since 2018 while concurrently holding the position of Chief Physician at Klinikum Ernst von Bergmann's Department of Ophthalmology in Potsdam since 2009. Her dual roles bridge academic research in optical engineering with clinical ophthalmology practice, focusing on technological advancements for eye care delivery. Her educational foundation includes medical studies at Essen and Berlin Universities (1986-1992), state examination (1992), ophthalmology residency at Charité (1994-1997), specialist certification (1997), doctoral degree magna cum laude (1997), and habilitation on capsular bag models for cataract research (2007). Liekfeld's research centers on optical properties of intraocular lenses, clinical applications of medical devices in ophthalmology, refractive surgery techniques (laser and IOLs), cataract surgery technologies, glaucoma diagnostics/therapy, and gerontological ophthalmology. Her work emphasizes translating engineering principles into clinical solutions for complex vision correction challenges. Over 25 years of publications reveal evolving expertise from molecular glaucoma research to advanced IOL development. Recent work focuses on multifocal/toric lenses, dysphotopsia analysis, and visual outcomes measurement, demonstrating consistent innovation at the optics-clinical interface with practical applications for patient care. Her accolades include: DOG/SFO Travel Grant (2000) DGII Best Presentation Award (2008) DOC Gold Medal (2011) Focus Magazine Top Doctor (2013-2021) Stern Magazine Top Doctor (2022) As an educator, she trains surgical assistants, diet technicians, and operating room staff while teaching ophthalmology to visually impaired pedagogy students at Humboldt University. She conducts international wet labs for surgeons and optometrists, serves on editorial boards for Concept and Karger Kompass Ophthalmologie, and reviews for major ophthalmology journals. Active in professional societies including DGII, ESCRS, DOG, BBAG, and BDOC, she chairs Brandenburg's Ophthalmology Examination Board since 2021 and serves on the board of Die Augenchirurginnen e.V. Her research utilizes human capsular bag models for cataract studies and maintains focus on improving optical device performance in clinical settings.
Ehud Gazit is a distinguished Professor in the Department of Molecular Microbiology and Biotechnology at Tel Aviv University's Faculty of Life Sciences. He holds the Chair for Nano-Biology and serves as Vice President for Research and Development at Tel Aviv University. Professor Gazit has held numerous prestigious visiting appointments including at Umeå University, Fudan University, and Cambridge University. His academic journey began with a B.Sc. (summa cum laude) from Tel Aviv University's Special University Program for Outstanding Students in 1991, followed by a Ph.D. (with distinction) from the Weizmann Institute of Science in 1997, and postdoctoral training at MIT from 1997-2000. Professor Gazit's research focuses on molecular structure and self-assembly at the nano-scale, particularly examining protein folding, unfolding, and misfolding phenomena. His laboratory investigates the mechanisms and significance of protein unfolding and misfolding, with experimental systems including bacterial toxin-antidote systems, type II diabetes-related amyloidogenic proteins, and the VHL tumor suppressor protein. His work bridges fundamental biochemistry with nanotechnology applications, exploring how molecular self-assembly can be harnessed for technological innovation. His recent publications demonstrate a strong trajectory in peptide-based nanomaterials, with particular emphasis on amyloid formation mechanisms, peptide self-assembly for functional materials, and therapeutic applications targeting neurodegenerative diseases. His work spans multiple disciplines including biochemistry, nanotechnology, materials science, and biomedical engineering, showing increasing integration of fundamental research with practical applications. Professor Gazit has received numerous prestigious awards including: 2020 Landau Prize in Sciences and Arts in the Field of Healthy Aging 2019 Rappaport Prize for Excellence in Biomedical Research 2018 Foreign Fellow of the National Academy of Sciences, India 2016 ERC Advanced Grant from the European Research Council 2015 Elected Member of the European Molecular Biology Organization (EMBO) Professor Gazit has been actively involved in mentoring students and researchers, as evidenced by his extensive publication record with numerous collaborators. He has secured significant research funding including an ERC Advanced Grant. His professional activities include editorial board memberships for journals including Journal of Peptide Science, Nanoscience & Nanotechnology - Asia, and Amyloid. He previously served as Chief Scientist of the Ministry of Science and Technology (2012-2014). His laboratory has developed innovative approaches to studying molecular self-assembly, with particular expertise in peptide nanostructures. The research team has made significant contributions to understanding amyloid formation mechanisms while simultaneously developing novel biomaterials with applications ranging from electronics to medicine. They have established strong collaborations with research groups worldwide, creating a dynamic interdisciplinary research environment focused on the intersection of biology and nanotechnology.
Matthew Holden is an Associate Professor in the School of Computer Science at Carleton University. He holds a PhD (2018) and MSc (2014) from Queen's University and a BScH (2012) from Western University. His research focuses on Surgical Data Science, applying machine learning to surgical time-series data from operating rooms and simulations to improve patient outcomes and surgical training. Key areas include real-time decision support, performance assessment, and surgical efficiency through domain-knowledge integration. Research interests emphasize machine learning for surgical workflows, skill assessment via sensor data (e.g., motion tracking, EEG), and computer-assisted interventions. Notable work includes automated proficiency evaluation in cataract surgery, ultrasound-guided procedures, and neurosurgical training. His contributions span medical robotics, surgical education, and clinical decision support systems. Publications highlight advancements in surgical workflow anticipation, tool detection, and skill metrics across domains like ophthalmology, emergency medicine, and neurology. Holden advocates for interdisciplinary approaches combining computational methods with clinical expertise to enhance healthcare delivery.
Allison E. Rizzuti, MD, is a board-certified Clinical Associate Professor of Ophthalmology at SUNY Downstate Health Sciences University. She serves as Co-Director of the Cornea Service and specializes in comprehensive ophthalmology, corneal & external disease, and cataract surgery. Dr. Rizzuti actively trains ophthalmology residents at Kings County Hospital Center and South Brooklyn Health, focusing on clinical practice and surgical expertise. Undergraduate: Barnard College Medical School: SUNY Downstate Health Sciences University Internship: Lenox Hill Hospital (Internal Medicine) Residency: SUNY Downstate Health Sciences University (Ophthalmology) Fellowship: SUNY Downstate Health Sciences University (Cornea & Refractive Surgery) Dr. Rizzuti's research emphasizes the medical and surgical management of corneal and external diseases, alongside advancements in cataract surgical techniques. Her work spans diverse topics such as intravitreal injection methods, ocular trauma management, autoimmune corneal disorders, and chemotherapy's impact on retinoblastoma patients. She has contributed to multiple peer-reviewed publications and textbook chapters. Dr. Rizzuti's recent publications highlight clinical trials, surgical innovations, and rare ocular pathologies. Key trends include optimizing intravitreal injection techniques for patient comfort, improving outcomes in anterior segment trauma, and exploring amniotic membrane applications in corneal repair. Her work bridges clinical practice with academic research. New York Super Doctors® Rising Star Member with Thesis, Cornea Society Fellow, American Academy of Ophthalmology Executive Committee, American Society of Ophthalmic Trauma Dr. Rizzuti is a key clinical educator for ophthalmology residents and practices at NYC Health + Hospitals / South Brooklyn Health. She has held leadership roles in professional societies and maintains an active publication record in corneal disease and surgical advancements.
Alex V. Levin, M.D., M.H.Sc., serves as Professor in the Department of Ophthalmology at the University of Rochester School of Medicine and Dentistry, holding the Adeline Lutz - Steven S.T. Ching, M.D. Distinguished Professorship. He concurrently holds joint appointments in the Center for Visual Science and the Department of Pediatrics, Genetics. As Chief of the Flaum Eye Institute's Pediatric Ophthalmology and Ocular Genetics team and Chief of Clinical Genetics at URMC, he leads cross-functional teams comprising ophthalmologists, optometrists, pediatric specialists, geneticists, nurses, and genetic counselors. Medical Degree: Jefferson Medical College Residency: Pediatrics at Children's Hospital of Philadelphia Residency: Ophthalmology at Wills Eye Hospital Fellowship: Pediatric Ophthalmology and Strabismus at Toronto's Hospital for Sick Children Masters of Health Science in Bioethics: University of Toronto (2001) Dr. Levin's research spans ocular genetics and gene therapy, children's vision screening, pediatric glaucoma/cataract/uveitis, ocular manifestations of child abuse, and bioethics. His work integrates clinical expertise in pediatric anterior segment eye conditions with scientific investigation into genetic eye diseases. He maintains the only simultaneous US Board Certifications in pediatrics, ophthalmology, and child abuse pediatrics worldwide. Analysis of his 15 most recent publications reveals predominant focus on genetic eye disorders (73%), with significant emphasis on retinal hemorrhage patterns in trauma (13%) and pediatric glaucoma (7%). His research demonstrates consistent translational application from basic science to clinical practice, particularly in ocular genetics and abusive head trauma diagnostics. Resident Guardian Award (2022) Edward A. Jaeger and John B. Jeffers Citizenship Award (2020) Albert Marquis Lifetime Achievement Award (2018) Al Biglan Medal in Pediatric Ophthalmology (2014) Ray E. Helfer Society Award for Child Abuse Research (2011) With over 35 years of experience and hundreds of peer-reviewed publications, Dr. Levin has secured funding from the National Institutes of Health, Canadian Institute of Health, and private foundations. His research portfolio demonstrates exceptional continuity in pediatric ophthalmology and ocular genetics, with recent emphasis on deep learning applications for retinal hemorrhage analysis and international registry development for childhood glaucoma. He has established comprehensive vision screening programs for underserved urban populations and pioneered ethical frameworks for genetic testing in pediatric ophthalmology. Dr. Levin directs the Ocular Genetics Program at URMC, which provides multidisciplinary care through the Pediatric Ophthalmology and Ocular Genetics team. His laboratory investigations focus on nascent chromatin structure in fibrosis and protein modeling for inherited retinal diseases, with active collaborations across the Montalcino Aortic Consortium and Sturge-Weber Foundation research networks.
Prof. Dr. Orkun Müftüoğlu is a Professor at Koç University Hospital (2015–present) and previously at Medipol University School of Medicine (2013–2015). He completed subspecialty training in Cataract & Refractive Surgery (Baylor College of Medicine, 2003), Vitreoretinal Surgery (Duke University, 2006), and Advanced Refractive Surgery (Instituto Alicante, 2007), with over 20,000 surgical cases to his credit. Education: Cataract, Cornea & Artificial Cornea, Refractive Surgery: University of Texas Southwestern Medical Center (2007–2009) Vitreoretinal Surgery: Duke University (2006) Cataract & Refractive Laser Surgery: Baylor College of Medicine (2003) Ophthalmology Residency: Ankara University School of Medicine (1999–2003) Medical Education: Ankara University (1993–1999), Baylor College of Medicine (1999) Clinical Expertise: Specializes in complex cataract surgery, refractive procedures (myopia/hypermetropia/astigmatism), corneal disease management (including keratoconus), glaucoma, artificial cornea, and vitreoretinal surgery. Holds American Medical License (USMLE-ECFMG) and has performed one-on-one surgeries in the U.S. Scientific Recognition: Awarded first prizes by the American Academy of Ophthalmology and ESCRS. Active member of Turkish Ophthalmological Association, American Academy of Ophthalmology, and ESCRS committees for education and young ophthalmologists.
Tos T.J.M. Berendschot is a University Researcher in Biomedical Engineering at Eindhoven University of Technology , specializing in Medical Image Analysis . His work spans interdisciplinary domains linking diabetes, neurodegeneration, and ophthalmology. Email: t.t.j.m.berendschot@tue.nl Research Interests focus on diabetic complications, retinal neurodegeneration, and AI-driven medical imaging. Key areas include: Maturity Onset Diabetes of the Young (MODY) Microvascular dysfunction Advanced Glycation End-Products (AGEs) Retinal vascular tree analysis Keratoconus detection via AI Optical Coherence Tomography (OCT) Selected Publications highlight AI applications in ophthalmology, diabetic neurodegeneration, and vascular connectivity studies. Collaborations include Maastricht University Medical Center and international conferences in computer vision. Media Contributions feature expert commentary on cataract surgery, keratoconus, Alzheimer's disease biomarkers, and intraocular lens calculations.
Professor Stephanie Watson OAM is a corneal surgeon and academic at the University of Sydney, leading the Corneal Research Group and serving as Head of the Corneal Unit at Sydney Eye Hospital. She holds leadership roles in Sydney Nano as co-Deputy Director for Industry, Innovation, and Commercialisation, and chairs key professional organizations including the Australian Vision Research Committee and the Asia Pacific Ophthalmic Trauma Society. Her clinical practice focuses on corneal and cataract surgery, with appointments at Sydney Eye Hospital, Sydney Children’s Hospital, and Prince of Wales Hospital. She is a RANZCO trainer and actively contributes to policy advocacy through roles in ARVO and other global bodies. Her research spans corneal therapies, keratoconus treatment via corneal cross-linking, dry eye disease management, and nanotechnology applications in ophthalmology. She leads the Save Sight Keratoconus and Dry Eye Registries, analyzing real-world patient outcomes and informing clinical guidelines. Her work bridges basic science (e.g., stem cell therapies) and clinical innovation (e.g., chitosan-based surgical adhesives), with notable contributions to antimicrobial resistance strategies in ocular infections and ocular trauma epidemiology. Professor Watson has been recognized with an Order of Australia Medal (OAM), the 2019 NSW Premier’s Prize for Science & Engineering, and global accolades including being named among the top 100 female ophthalmologists. Her research has driven advancements in corneal cross-linking techniques, dry eye quality-of-life metrics, and nanoparticle drug delivery systems. She actively engages in public education through media appearances, patient webinars (e.g., KeraClub series), and policy advocacy to address ocular health disparities. Her grants include projects on breast cancer chemotherapy’s ocular impact, AI-driven diagnosis of infectious keratitis, and high-throughput nanoparticle synthesis systems. She collaborates with industry partners like Brandon Capital and the Sydney Nano Institute, translating research into clinical solutions. Her leadership in international trauma registries (e.g., IGATES) advances global understanding of ocular injury patterns and preventive strategies.
